Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FBTAX vs. FBDIX: which is better?

Bottom line

FBTAX vs FBDIX: the short answer

FBTAX (Fidelity Advisor Biotechnology Fund) and FBDIX (Franklin Biotechnology Discovery Fund) are quite different portfolios: only about 39% of their top holdings (by weight) are shared.

FBTAX is cheaper at 0.94% vs 1.01% — a difference of $7.00 a year per $10,000 invested.

Over five years, FBTAX returned +6.4% a year vs +5.0% for FBDIX (reporting dates differ).

FBDIX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

FBTAX vs FBDIX side by side

FBTAXFBDIX
TypeMutual fundMutual fund
Fund familyFidelityFranklin Templeton
CategoryTechnology SectorTechnology Sector
Expense ratio0.94%1.01%
Annual cost per $10k$94$101
10-yr cost on $10k (prospectus)$1,663$1,728
Max front load—5.5%
12b-1 fee0.25%0.25%
1-yr return+31.5%+43.9%
5-yr return (annualized)+6.4%+5.0%
10-yr return (annualized)+7.7%+6.4%
Best quarter+30.3%+29.5%
Worst quarter−27.8%−24.5%
Net assets (fund)$2.2B$1.2B
Number of holdings129126
Portfolio turnover54%38%
Returns as ofSep 30, 2026Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFBTAXFBDIXDifference
2025+39.6%+52.3%−12.8%
2024+5.3%+4.0%+1.3%
2023+10.7%+18.4%−7.7%
2022−8.0%−12.7%+4.7%
2021−3.6%−17.7%+14.1%
2020+32.2%+29.9%+2.3%
2019+25.7%+34.8%−9.1%
2018−3.8%−15.7%+11.9%
2017+25.8%+18.8%+7.0%
2016−23.6%−17.2%−6.4%

Source: Fund prospectus bar charts

Holdings overlap

11 of FBTAX's top 25 holdings also appear in FBDIX's top 25.

Shared top holdings
HoldingFBTAXFBDIX
Gilead Sciences Inc5.70%3.86%
Spyre Therapeutics Inc3.83%1.87%
Dianthus Therapeutics Inc3.55%2.32%
Oruka Therapeutics Inc3.24%1.86%
Insmed Inc3.05%1.99%
Revolution Medicines Inc3.00%3.01%
Argenx Se3.00%3.62%
Ascendis Pharma A/s2.99%2.56%
Amgen Inc2.37%4.39%
Amylyx Pharmaceuticals Inc2.25%1.32%
Vertex Pharmaceuticals Inc1.39%3.54%

Source: SEC Form N-PORT

FBTAX top 10

  1. Abbvie Inc — 14.71%
  2. Gilead Sciences Inc — 5.70%
  3. Spyre Therapeutics Inc — 3.83%
  4. Alnylam Pharmaceuticals Inc — 3.62%
  5. Dianthus Therapeutics Inc — 3.55%
  6. Cogent Biosciences Inc — 3.25%
  7. Oruka Therapeutics Inc — 3.24%
  8. Insmed Inc — 3.05%
  9. Revolution Medicines Inc — 3.00%
  10. Argenx Se — 3.00%

FBDIX top 10

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Revolution Medicines, Inc. — 3.01%
  9. Guardant Health, Inc. — 2.76%
  10. Ascendis Pharma A/S — 2.56%

FAQ

What is the difference between FBTAX and FBDIX?
FBTAX (Fidelity Advisor Biotechnology Fund) and FBDIX (Franklin Biotechnology Discovery Fund) are quite different portfolios: only about 39% of their top holdings (by weight) are shared. FBTAX is cheaper at 0.94% vs 1.01% — a difference of $7.00 a year per $10,000 invested.
Which is cheaper, FBTAX or FBDIX?
FBTAX has the lower expense ratio (0.94%).
Should I own both FBTAX and FBDIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.